• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAC
Click for more information
1.55% $1.31

RACE ONCOLOGY LTD

Market Cap $217.2M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Race Oncology Limited is an Australia-based precision oncology company with a Phase... Race Oncology Limited is an Australia-based precision oncology company with a Phase II/III cancer drug called Zantrene. Zantrene is a potent small molecule inhibitor of the Fatso/Fat mass and obesity associated (FTO) protein. The Company is exploring the use of Zantrene as a new therapy for melanoma and clear cell renal cell carcinoma (kidney cancer), which are both frequent FTO-driven cancers. Zantrene (bisantrene dihydrochloride) is a small molecule anti-cancer drug which has clinical and preclinical efficacy as both a low dose, highly targeted precision oncology agent and a cardio-protective chemotherapeutic. The Company also has clinical data for the use of Zantrene as a chemotherapeutic agent with reduced cardiotoxicity in acute myeloid leukemia (AML), breast and ovarian cancers and is investigating its use in these areas.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RAC
RAC - Charts & Price Action
342 343 344
17:00 20K 6.9M
17:00 Last post  Hunterr Comments Created with Sketch.  20K  Views Created with Sketch.  6.9M 
RAC
Ann: Quarterly Activity Report & Appendix 4C
2 3
14:09 126 26K
14:09 Last post  asx11 Comments Created with Sketch.  126  Views Created with Sketch.  26K 
RAC
Cardioprotection thread
6 7 8
13:19 432 117K
13:19 Last post  ma420 Comments Created with Sketch.  432  Views Created with Sketch.  117K 
RAC
General Comments / Chat
180 181 182
10:23 10K 3.7M
10:23 Last post  Hunterr Comments Created with Sketch.  10K  Views Created with Sketch.  3.7M 
RAC
Ann: Application for quotation of securities - RAC 		26/04/24 1 539
26/04/24 Last post  TIAA2020 Comments Created with Sketch.  1  Views Created with Sketch.  539 
RAC
Ann: Notification regarding unquoted securities - RAC 		26/04/24 2 658
26/04/24 Last post  johndprent Comments Created with Sketch.  2  Views Created with Sketch.  658 
RAC
CEOs buying and commenting on other company stock: A Hit or a Miss? 		25/04/24 4 1.1K
25/04/24 Last post  ttppxx Comments Created with Sketch.  4  Views Created with Sketch.  1.1K 
RAC
RAC media coverage
33 34 35
22/04/24 2.0K 668K
22/04/24 Last post  Boffin99 Comments Created with Sketch.  2.0K  Views Created with Sketch.  668K 

See All Discussions arrow Created with Sketch.

Timeline

Notification regarding unquoted securities - RAC
26 Apr 13:14
 
Application for quotation of securities - RAC
26 Apr 13:13
 
Notification regarding unquoted securities - RAC
18 Apr 13:07
 
Application for quotation of securities - RAC
18 Apr 13:05
 
Quarterly Activity Report & Appendix 4C
18 Apr 12:21
 
Notification regarding unquoted securities - RAC
11 Apr 13:53
 
View More arrow Created with Sketch.

Featured News

BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.

(20min delay)
Last
$1.31 		Change
0.020(1.55%) 		Mkt cap ! $217.2M
Open High Low Value Volume
$1.31 $1.31 $1.26 $71.25K 55.65K

Buyers (Bids)

No. Vol. Price($)
1 200 $1.27
 

Sellers (Offers)

Price($) Vol. No.
$1.31 5950 3
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
$1.31 		  Change
0.020 ( 2.18 %)
Open High Low Volume
$1.30 $1.31 $1.26 10789
Last updated 15.59pm 26/04/2024 ?
RAC (ASX) Chart

Top Stories

BHP confirms £31.1B takeover bid for Anglo American

BHP HAS confirmed its offer to takeover fellow mining giant Anglo American plc, following press speculation of a potential deal.which had unsettled shareholder groups and financial firms in London, and provoked criticism from a South African government minister.
Regal copper grades at Gascoyne play see shares jump 33% for Augustus Augustus Minerals is reporting high grade copper rock chip results at Ti-Tree in WA based on recent fieldwork.
Crypto world awaits overnight Bitcoin halving event The four-yearly Bitcoin halving is set to happen in the early hours of tomorrow morning (Saturday, April 20) - it's an event that industry leader Swyftx likened to 'the Olympic Games for the crypto industry'.
1970s on repeat, but there's a silver lining! ABBA fans across Australia know that the 1970s were not only about nervous shuffles to the strains of Dancing Queen, across the linoleum floor at the local Blue Light Disco. Oil had only recently begun to rise, and so synthetic fabrics, like polyester, were very popular. So was central heating, using fuel oil. This is all ancient history now and it would not matter except for the fact that history is now rhyming so hard.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.

Featured News

CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.